Compare Abeona Therapeutics Inc (ABEO) vs Packaging Corporation of America (PKG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Packaging Corporation of America — how do they compare? Abeona Therapeutics Inc trades at $6.69 (market cap $373.32M), while Packaging Corporation of America trades at $224.44 (market cap $20.71B). The key difference: Packaging Corporation of America is far larger — about 55.5× Abeona Therapeutics Inc's market cap, and Packaging Corporation of America pays a 2.58% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | PKG | |
|---|---|---|
Market Cap | $373.32M | $20.71B |
Sector | Health | Technology |
52-Week High | $7.23 | $246.31 |
52-Week Low | $4.17 | $191.41 |
Enterprise Value | $228.22M | $24.53B |
Dividend Yield | — | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Packaging Corporation of America (PKG) trades at $236.39, down 0.76% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported a Q1 2026 EPS beat of $2.40 versus $2.14 expected, with revenue growth to $2.4 billion. Recent news highlights a 20% dividend increase to an annual $6.00 per share and upcoming Q2 2026 earnings call on July 23, 2026.
PKG presents a mixed outlook with strong profitability metrics like a 16.21% ROE and 8.04% net margin, but faces margin pressure and two recent earnings misses. The consensus price target of $245 suggests modest upside, though risks include input cost inflation and competitive pressures. Institutional sentiment is cautiously optimistic with 38% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
